Supernus Pharmaceuticals, Inc.
Clinical trials sponsored by Supernus Pharmaceuticals, Inc., explained in plain language.
-
New hope for patients with Life-Threatening seizures that Won't stop
Disease control NO_LONGER_AVAILABLEThis study provides access to an experimental drug, SAGE-547, for people aged 6 months and older with super-refractory status epilepticus—a dangerous condition where seizures continue despite standard treatments. The drug is given as a continuous IV infusion to try to stop the se…
Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 10:01 UTC
-
New hope for new moms: early access to postpartum depression drug
Disease control APPROVED_FOR_MARKETINGThis program offers early access to ZULRESSO (brexanolone) for a limited number of adult women with postpartum depression before the drug is commercially available. A healthcare provider must request access for a specific patient, and both the patient and provider must agree that…
Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 09:56 UTC